MyFinsight
Home
Blog
About
Back
Income Statement
Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc. (AVIR)
source: myfinsight.com
Comprehensive loss
-$32,932K
(11.57%↑ Y/Y)
Unrealized gain (loss) on
available-for-sale investments
$1K
(101.23%↑ Y/Y)
Net loss
-$32,933K
(11.38%↑ Y/Y)
Loss before income
taxes
-$32,909K
(10.95%↑ Y/Y)
Income tax expense
$24K
(-88.41%↓ Y/Y)
Interest income and
other, net
$2,190K
(-50.13%↓ Y/Y)
Loss from operations
-$35,099K
(15.11%↑ Y/Y)
Total operating
expenses
$35,099K
(-15.11%↓ Y/Y)
Research and development
$28,150K
(-12.78%↓ Y/Y)
General and
administrative
$6,949K
(-23.38%↓ Y/Y)
Back